Finally! FDA Announces Highly-Anticipated and Long-Awaited Public Hearing on “Off-Label” Communications
It’s Settled … At Least Somewhat: Settlement of the First Amendment Case Amarin Pharma v. FDA
Pacira settlement could have ripple effects on a range of FDA issues far beyond promotional claims
FDA Settles Pacira’s First Amendment Lawsuit
Recent First Amendment Rumblings
CEO Media Statements Draw Additional Scrutiny
FDA Withdraws Draft Disease Awareness Guidance
Less is More in FDA’s Eyes: FDA’s Revised Draft Guidance on Disclosing Risk Information
FDA Provides New Framework for Drug and Device Promotion on Twitter and Search Engines
Subscribe: Subscribe via RSS
Blogs
Firm/Org